RTSN insider filings
Retension Pharmaceuticals, Inc. — 23 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-04. Screen RTSN transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 23 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings by 2 insiders — 30,800 shares, $369,600 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 20,800 shares @ $12.00 ($249,600) by Keller Eric L., filed 2026-10-13.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Keller Eric L. — CHIEF EXECUTIVE OFFICER, Director | 3 | 1 leg · 20,800 sh · $249,600 | — | 6 |
| BERGER FRANKLIN M — Director | 3 | 1 leg · 10,000 sh · $120,000 | — | 3 |
| BERENDT MICHAEL J — Director | 3 | — | — | 5 |
| Bisson Sabine — CHIEF OPERATING OFFICER | 2 | — | — | 4 |
| Sweetnam Paul — CHIEF SCIENTIFIC OFFICER | 2 | — | — | 4 |
| Olds Donald — Director | 3 | — | — | 3 |
| Cheruvu Pavan — Director | 2 | — | — | 1 |
| Wong Robert — VP, Chief Accounting Officer | 2 | — | — | 1 |
| B Group, Inc. — 10% owner | 1 | — | — | — |
| Schecter Alison D. — Chief Medical Officer | 1 | — | — | — |
+1 more insider in the window, not shown — every filing appears in the table below.
Recent insider filings — Retension Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Wong Robert — VP, Chief Accounting Officer | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-11-04 | 3 | Wong Robert — VP, Chief Accounting Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-22 | 4 | Keller Eric L. — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 40,884 (derivative) @ $0 | EDGAR |
| 2026-10-16 | 3 | B Group, Inc. — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2026-10-13 | 4 | Cheruvu Pavan — Director | Grant/award (A): 5,636 (derivative) @ $0 | EDGAR |
| 2026-10-13 | 4 | Olds Donald — Director | Conversion (C): 5,637 · Conversion (C): 5,637 (derivative) | EDGAR |
| 2026-10-13 | 4 | Sweetnam Paul — CHIEF SCIENTIFIC OFFICER | Conversion (C): 4,026 · Conversion (C): 2,640 · Conversion (C): 4,026 (derivative) · Conversion (C): 2,640 (derivative) | EDGAR |
| 2026-10-13 | 4 | Keller Eric L. — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 20,800 @ $12 · Conversion (C): 9,662 · Conversion (C): 31,368 · Grant/award (A): 255,174 (derivative) @ $0 · Conversion (C): 9,662 (derivative) · Conversion (C): 31,368 (derivative) | EDGAR |
| 2026-10-13 | 3 | Cheruvu Pavan — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-13 | 4 | BERENDT MICHAEL J — Director | Conversion (C): 4,026 · Conversion (C): 2,640 · Conversion (C): 4,026 (derivative) · Conversion (C): 2,640 (derivative) | EDGAR |
| 2026-10-13 | 4 | BERGER FRANKLIN M — Director | Conversion (C): 12,517 · Purchase (P): 10,000 @ $12 · Conversion (C): 12,517 (derivative) | EDGAR |
| 2026-10-13 | 4 | Bisson Sabine — CHIEF OPERATING OFFICER | Conversion (C): 1,611 · Conversion (C): 2,504 · Conversion (C): 1,611 (derivative) · Conversion (C): 2,504 (derivative) | EDGAR |
| 2026-10-08 | 4 | Olds Donald — Director | Grant/award (A): 5,636 (derivative) @ $0 | EDGAR |
| 2026-10-08 | 4 | BERENDT MICHAEL J — Director | Grant/award (A): 5,636 (derivative) @ $0 | EDGAR |
| 2026-10-08 | 4 | BERGER FRANKLIN M — Director | Grant/award (A): 5,636 (derivative) @ $0 | EDGAR |
| 2026-10-08 | 3 | Schwartz Alexander Duke — Chief Financial Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | Olds Donald — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | Schecter Alison D. — Chief Medical Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | Sweetnam Paul — Chief Scientific Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | BERENDT MICHAEL J — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | BERGER FRANKLIN M — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | Bisson Sabine — Chief Operating Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | Keller Eric L. — Chief Executive Officer, Director | Holdings only — no transactions reported | EDGAR |
Recent 8-K events — Retension Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-18 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-13 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Retension Pharmaceuticals, Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-299024 (S-1) — latest: Final prospectus (424B4), filed 2026-10-09
GET https://api.filingpulse.io/v1/insider-trades?ticker=RTSN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs